Applied Therapeutics, Inc. — Director's Dealing 2025

Jun 17, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2025-06-15

Reporting Person: Bailey Evan Prescott (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	541669	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.50	2031-09-14	Common Stock (19531)		Direct
Stock Option (Right to Buy)	$1.50	2032-04-13	Common Stock (4883)		Direct

Footnotes

F1: These options are fully vested.

F2: Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option vested on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.